alpha-synuclein aggregation inhibitor (Institute of Organic Chemistry And Biochemistry)

N/A

Report date: 2025/06/11 10:45:28
NME

Base Information

Drug Namealpha-synuclein aggregation inhibitor (Institute of Organic Chemistry And Biochemistry)
Drug Alias NameFEPI4
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSynuclein alpha inhibitors
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesICOB TECHNOLOGY LLCInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A